Alkermes (ALKS) Income from Continuing Operations (2010 - 2026)

Alkermes (ALKS) reported Income from Continuing Operations of 66526000.0 for Q1 2026, down 395.82% year-over-year from 22489000.0 in Q1 2025, and down 234.69% quarter-over-quarter from 49391000.0 in Q4 2025.

Alkermes (ALKS) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Income from Continuing Operations data on file, last reported at 66526000.0 in Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 66526000.0, down 395.82% year-over-year; the trailing twelve-month figure through Mar 2026 was 152749000.0 (down 57.05% YoY), and the FY2025 annual result was 241664000.0, down 35.06% from the prior year.
  • Income from Continuing Operations eased to 66526000.0 in Q1 2026 per ALKS's latest filing, from 49391000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 279129000.0 in Q2 2023 and troughed at 66526000.0 in Q1 2026.
  • A 5-year average of 55054411.76 and a median of 63173000.0 in 2023 frame the typical range for Income from Continuing Operations.
  • The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations sank 1374.79% in 2022, then jumped 1026.23% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 96861000.0 in 2022, then slumped by 34.78% to 63173000.0 in 2023, then surged by 130.7% to 145737000.0 in 2024, then slumped by 66.11% to 49391000.0 in 2025, then tumbled by 234.69% to 66526000.0 in 2026.
  • Business Quant data shows ALKS's Income from Continuing Operations at 66526000.0 in Q1 2026, 49391000.0 in Q4 2025, and 82745000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 52.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -66.53 Mn
Dec 31, 2025 49.39 Mn
Sep 30, 2025 82.75 Mn
Jun 30, 2025 87.14 Mn
Mar 31, 2025 22.49 Mn
Dec 31, 2024 145.74 Mn
Sep 30, 2024 92.80 Mn
Jun 30, 2024 94.62 Mn
Mar 31, 2024 38.91 Mn
Dec 31, 2023 63.17 Mn
Sep 30, 2023 91.51 Mn
Jun 30, 2023 279.13 Mn
Mar 31, 2023 -12.03 Mn
Dec 31, 2022 96.86 Mn
Sep 30, 2022 -63.97 Mn
Jun 30, 2022 -30.14 Mn
Mar 31, 2022 -35.90 Mn
Dec 31, 2021 135.97 Mn
Sep 30, 2021 -28.99 Mn
Jun 30, 2021 2.36 Mn